Trials in New York, New York
Here are the top 10 medical studies for breast cancer in New York, New York
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Trastuzumab Deruxtecan for Metastatic Breast Cancer
Recruiting2 awardsPhase 3
Toronto, Ontario
This trial will compare trastuzumab deruxtecan to other treatments for patients with HER2-low breast cancer that cannot be removed by surgery and has spread. The treatment targets and kills cancer cells by delivering chemotherapy directly to them. Trastuzumab deruxtecan has shown effectiveness in patients with HER2-low breast cancer, resulting in longer periods without the disease getting worse and longer life expectancy compared to other chemotherapy treatments.
Monoclonal Antibodies
Pembrolizumab + Standard Therapy for Breast Cancer
Recruiting1 awardPhase 3
Toronto, Ontario
This trial is testing whether the cancer drug pembrolizumab is more effective than placebo when given with standard neoadjuvant and adjuvant therapy for high-risk early-stage ER+/HER2- breast cancer. The primary objectives are to compare pembrolizumab to placebo in terms of pathological complete response rate and event-free survival.
Trials With No Placebo
Selective Estrogen Receptor Modulator
Lasofoxifene vs Fulvestrant for Breast Cancer
Recruiting3 awardsPhase 2
Buffalo, New York
This trial evaluates the activity of a drug (lasofoxifene) to treat pre- and postmenopausal women with advanced breast cancer caused by an ESR1 mutation. It will measure progression free survival, clinical benefit, response rate, overall survival, QoL and safety.
Monoclonal Antibodies
Trastuzumab Deruxtecan for Metastatic Breast Cancer
Recruiting2 awardsPhase 3
Toronto, Ontario
This trial will compare trastuzumab deruxtecan to other treatments for patients with HER2-low breast cancer that cannot be removed by surgery and has spread. The treatment targets and kills cancer cells by delivering chemotherapy directly to them. Trastuzumab deruxtecan has shown effectiveness in patients with HER2-low breast cancer, resulting in longer periods without the disease getting worse and longer life expectancy compared to other chemotherapy treatments.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.